Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	antigen binding	IGHV2-26 HLA-DRB4 IGHV4-38-2 IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-30-4 IGHV4-28	2.21e-05	190	122	8	GO:0003823
GeneOntologyMolecularFunction	olfactory receptor activity	OR1M1 OR7G1 OR7A5 OR5G3 OR13C5 OR5H15 OR14C36 OR6V1 OR1Q1 OR1P1 OR5H1	6.83e-05	431	122	11	GO:0004984
GeneOntologyMolecularFunction	transcription coregulator activity	NCOA3 ARL2BP PIAS2 ZXDA JMJD1C ZXDB HIPK3 PPARGC1A ZMIZ2 ATF7IP2 TRIM8 WDR77	1.71e-04	562	122	12	GO:0003712
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	NCOA3 PPARGC1A ASXL3	2.73e-04	21	122	3	GO:0042975
GeneOntologyMolecularFunction	nuclear receptor coactivator activity	NCOA3 PPARGC1A ZMIZ2 WDR77	5.29e-04	61	122	4	GO:0030374
GeneOntologyMolecularFunction	transcription coactivator activity	NCOA3 ARL2BP ZXDA ZXDB PPARGC1A ZMIZ2 TRIM8 WDR77	5.53e-04	303	122	8	GO:0003713
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	NCOA3 ARL2BP COL19A1 ANK3 WNK1 PIAS2 ZXDA JMJD1C ZXDB HIPK3 KLHL3 PPARGC1A IGF2BP3 ZMIZ2 ATF7IP2 TRIM8 WDR77	6.89e-04	1160	122	17	GO:0030674
GeneOntologyMolecularFunction	nuclear receptor binding	NCOA3 PIAS2 JMJD1C PPARGC1A IPO13 FOXP1	1.02e-03	187	122	6	GO:0016922
GeneOntologyMolecularFunction	nuclear androgen receptor binding	NCOA3 PIAS2 FOXP1	1.06e-03	33	122	3	GO:0050681
GeneOntologyCellularComponent	immunoglobulin complex	IGHV2-26 IGKV6D-21 IGHV4-38-2 IGHV4-61 IGHV4-59 IGKV6-21 IGHV4-31 IGHV4-30-4 IGHV4-28	7.03e-07	166	125	9	GO:0019814
HumanPheno	Pseudohypoaldosteronism	WNK1 KLHL3 NR3C2	8.17e-06	6	39	3	HP:0008242
Domain	ASH	ASPM HYDIN	3.63e-05	2	113	2	IPR031549
Domain	ASH	ASPM HYDIN	3.63e-05	2	113	2	PF15780
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	PIK3CD IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	1.36e-05	53	82	5	MM15716
Pathway	REACTOME_OLFACTORY_SIGNALING_PATHWAY	OR1M1 OR7G1 OR7A5 OR5G3 OR13C5 OR5H15 OR14C36 OR6V1 OR1Q1 OR1P1 OR5H1	2.82e-05	417	82	11	M4072
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	4.85e-05	35	82	4	MM17219
Pathway	REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	7.49e-05	39	82	4	MM17212
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	1.32e-04	45	82	4	MM14912
Pathway	REACTOME_FCGR_ACTIVATION	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	1.70e-04	48	82	4	MM17214
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	2.70e-04	54	82	4	MM14655
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	3.10e-04	56	82	4	MM14815
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	3.55e-04	58	82	4	MM14914
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	4.05e-04	60	82	4	MM14872
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	4.05e-04	60	82	4	MM14913
Pubmed	Cloning, sequencing and expression of the rearranged MOPC 315 VH gene segment.	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	5.88e-09	7	127	4	2497341
Pubmed	Model-building studies of antigen-binding sites: the hapten-binding site of mopc-315.	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	5.88e-09	7	127	4	268248
Pubmed	Amino acid sequence of the precursor region of MOPC-315 mouse immunoglobulin heavy chain.	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	5.88e-09	7	127	4	414225
Pubmed	The idiotypic network and the internal image: possible regulation of a germ-line network by paucigene encoded Ab2 (anti-idiotypic) antibodies in the GAT system.	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	5.88e-09	7	127	4	3937730
Pubmed	The structure of the expressible VH gene from a hybridoma producing monoclonal antibodies against porcine transferrin.	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	5.88e-09	7	127	4	2587273
Pubmed	Amino-acid sequence of the variable region of the heavy (alpha) chain of a mouse myeloma protein with anti-hapten activity.	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	5.88e-09	7	127	4	4524622
Pubmed	A new germline VH36-60 gene is used in the neonatal primary and adult memory response to (T,G)-A--L.	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	5.88e-09	7	127	4	1683681
Pubmed	Structure and function of immunoglobulin genes and precursors.	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	3.50e-08	10	127	4	428562
Pubmed	Interaction network of human early embryonic transcription factors.	NCOA3 SOBP PIAS2 ASXL3 ZMIZ2 TET1 KMT2A FOXP1 QSER1 RAI1	7.10e-07	351	127	10	38297188
Pubmed	Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response.	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	1.18e-06	22	127	4	2499654
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	BRIP1 SYNPO PIAS2 JMJD1C PAPOLG SCML2 ANLN KMT2A BOD1L1 QSER1 RAI1 ZNF292	2.53e-06	608	127	12	36089195
Pubmed	NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.	JMJD1C BRCA2 TET1 QSER1	2.79e-06	27	127	4	23395962
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	NCOA3 PIAS2 BIRC6 JMJD1C BRCA2 ZMIZ2 TET1 BUB1B ATF7IP2 FOXP1	3.39e-06	418	127	10	34709266
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	IFT140 FNDC3A SYNPO ANKRD27 TET1 IPO13 PDCD11 PLAGL2 AGAP7P CPSF2 RAI1	4.13e-06	529	127	11	14621295
Pubmed	Different evolutionary processes shaped the mouse and human olfactory receptor gene families.	OR1M1 OR7G1 OR7A5 OR5G3 OR5H15 OR14C36 OR1Q1 OR1P1 OR5H1	4.73e-06	340	127	9	11875048
Pubmed	The olfactory receptor gene superfamily of the mouse.	OR1M1 OR7G1 OR7A5 OR5G3 OR5H15 OR14C36 OR1Q1 OR1P1 OR5H1	4.73e-06	340	127	9	11802173
Pubmed	A unified nomenclature for vertebrate olfactory receptors.	OR1M1 OR7G1 OR7A5 OR5G3 OR5H15 OR14C36 OR1Q1 OR1P1 OR5H1	5.08e-06	343	127	9	32295537
Pubmed	Odorant receptor expressed sequence tags demonstrate olfactory expression of over 400 genes, extensive alternate splicing and unequal expression levels.	OR1M1 OR7G1 OR7A5 OR5G3 OR5H15 OR14C36 OR1Q1 OR1P1 OR5H1	5.45e-06	346	127	9	14611657
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NCOA3 JMJD1C SCML2 ANLN KMT2A FOXP1 QSER1 RAI1	6.81e-06	268	127	8	33640491
Pubmed	The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome.	NCOA3 JMJD1C PPARGC1A	7.68e-06	11	127	3	36613751
Pubmed	Nonsyndromic Retinitis Pigmentosa Overview	SPATA7 IFT140 ARL2BP EYS USH2A	1.23e-05	81	127	5	20301590
Pubmed	Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias.	TET1 KMT2A	1.32e-05	2	127	2	23100278
Pubmed	LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23).	TET1 KMT2A	1.32e-05	2	127	2	12124344
Pubmed	The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1{alpha}.	NCOA3 PPARGC1A	1.32e-05	2	127	2	18957541
Pubmed	Mutation affecting the conserved acidic WNK1 motif causes inherited hyperkalemic hyperchloremic acidosis.	WNK1 KLHL3	1.32e-05	2	127	2	32790646
Pubmed	Potential role of BRCA2 in a mitotic checkpoint after phosphorylation by hBUBR1.	BRCA2 BUB1B	1.32e-05	2	127	2	10749118
Pubmed	A novel ADAMTS17 variant that causes Weill-Marchesani syndrome 4 alters fibrillin-1 and collagen type I deposition in the extracellular matrix.	FBN1 ADAMTS17	1.32e-05	2	127	2	31726086
Pubmed	Role of KLHL3 and dietary K+ in regulating KS-WNK1 expression.	WNK1 KLHL3	1.32e-05	2	127	2	33682442
Pubmed	Duplicated zinc finger protein genes on the proximal short arm of the human X chromosome: isolation, characterization and X-inactivation studies.	ZXDA ZXDB	1.32e-05	2	127	2	8268913
Pubmed	The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group.	TET1 KMT2A	1.32e-05	2	127	2	19144982
Pubmed	First description of the t(10;11)(q22;q23)/MLL-TET1 translocation in a T-cell lymphoblastic lymphoma, with subsequent lineage switch to acute myelomonocytic myeloid leukemia.	TET1 KMT2A	1.32e-05	2	127	2	24323992
Pubmed	The role of germline alterations in the DNA damage response genes BRIP1 and BRCA2 in melanoma susceptibility.	BRIP1 BRCA2	1.32e-05	2	127	2	27074266
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	BRIP1 FNDC3A WNK1 BIRC6 JMJD1C PAPOLG SCML2 ANLN BOD1L1 QSER1 CPSF2 AGTPBP1	1.66e-05	733	127	12	34672954
Pubmed	Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.	BRIP1 HUS1 PPARGC1A CLCA2 BRCA2	1.95e-05	89	127	5	18950845
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	NCOA3 SOBP JMJD1C BRCA2 ZMIZ2 TRIM8	2.11e-05	152	127	6	38360978
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	JMJD1C ATP2C1 WDR11 BOD1L1 CPSF2 HEATR5B	2.19e-05	153	127	6	10718198
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PDE4D ANK3 SOBP SYNPO JMJD1C C2CD2 SGK2 HIPK3 ATP2C1 WDR11 ZNF827 RIN2 FOXP1 BOD1L1 ANKRD12 QSER1 RAI1	3.09e-05	1489	127	17	28611215
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ANK3 JMJD1C SCML2 ANLN TET1 BUB1B PDCD11 KMT2A BOD1L1 QSER1	3.56e-05	549	127	10	38280479
Pubmed	Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression.	IGF2BP3 WDR11 ANLN FOXP1 HYDIN	3.76e-05	102	127	5	31623628
Pubmed	CircRNA circHIPK3 serves as a prognostic marker to promote glioma progression by regulating miR-654/IGF2BP3 signaling.	HIPK3 IGF2BP3	3.96e-05	3	127	2	30057315
Pubmed	Impaired phosphorylation and mis-localization of Bub1 and BubR1 are responsible for the defective mitotic checkpoint function in Brca2-mutant thymic lymphomas.	BRCA2 BUB1B	3.96e-05	3	127	2	14646599
Pubmed	WNK1 regulates skeletal muscle cell hypertrophy by modulating the nuclear localization and transcriptional activity of FOXO4.	WNK1 KLHL3	3.96e-05	3	127	2	29904119
Pubmed	Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.	WNK1 KLHL3	3.96e-05	3	127	2	24821705
Pubmed	TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23).	TET1 KMT2A	3.96e-05	3	127	2	12646957
Pubmed	Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers.	NCOA3 BRCA2	3.96e-05	3	127	2	14648706
Pubmed	Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene.	NCOA3 BRCA2	3.96e-05	3	127	2	15900600
Pubmed	Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis.	FBN1 BRCA2	3.96e-05	3	127	2	25749384
Pubmed	Polymorphic repeat length in the AIB1 gene and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis of observational studies.	NCOA3 BRCA2	3.96e-05	3	127	2	23483928
Pubmed	The AIB1 gene polyglutamine repeat length polymorphism and the risk of breast cancer development.	NCOA3 BRCA2	3.96e-05	3	127	2	20422428
Pubmed	Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.	NCOA3 JMJD1C PPARGC1A	6.03e-05	21	127	3	19596656
Pubmed	Negative modulation of androgen receptor transcriptional activity by Daxx.	NCOA3 PIAS2 PPARGC1A	6.96e-05	22	127	3	15572661
Pubmed	Differences between germ-line and rearranged immunoglobulin V kappa coding sequences suggest a localized mutation mechanism.	IGKV6D-21 IGKV6-21	7.90e-05	4	127	2	6264318
Pubmed	FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi Anemia core complex.	BRIP1 BRCA2	7.90e-05	4	127	2	25659033
Pubmed	Chromosomal organization of the human VH4 gene family. Location of individual gene segments.	IGHV4-59 IGHV4-31	7.90e-05	4	127	2	8454861
Pubmed	Characterization of a novel small molecule subtype specific estrogen-related receptor alpha antagonist in MCF-7 breast cancer cells.	NCOA3 PPARGC1A	7.90e-05	4	127	2	19462000
Pubmed	Pseudohypoaldosteronism Type II	WNK1 KLHL3	7.90e-05	4	127	2	22073419
Pubmed	Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4.	WNK1 KLHL3	7.90e-05	4	127	2	23576762
Pubmed	Defects of FA/BRCA pathway in lymphoma cell lines.	BRIP1 BRCA2	7.90e-05	4	127	2	19011769
Pubmed	Weill-Marchesani Syndrome	FBN1 ADAMTS17	7.90e-05	4	127	2	20301293
Pubmed	Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.	TET1 KMT2A	7.90e-05	4	127	2	26791235
Pubmed	Specific repertoire of olfactory receptor genes in the male germ cells of several mammalian species.	OR1M1 OR7A5 OR1Q1	9.10e-05	24	127	3	9119360
Pubmed	Modulation of the combinatorial code of odorant receptor response patterns in odorant mixtures.	OR7A5 OR14C36 OR5H1	1.30e-04	27	127	3	32061665
Pubmed	Association analysis of 528 intra-genic SNPs in a region of chromosome 10 linked to late onset Alzheimer's disease.	ANK3 TET1	1.31e-04	5	127	2	18163421
Pubmed	Structural and biochemical characterization of the KLHL3-WNK kinase interaction important in blood pressure regulation.	WNK1 KLHL3	1.31e-04	5	127	2	24641320
Pubmed	Proper chromosome alignment depends on BRCA2 phosphorylation by PLK1.	BRCA2 BUB1B	1.31e-04	5	127	2	32286328
Pubmed	The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity.	PIAS2 ZMIZ2	1.31e-04	5	127	2	16777850
Pubmed	Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor.	NCOA3 PPARGC1A	1.31e-04	5	127	2	18798693
Pubmed	Activation of BRCA1/BRCA2-associated helicase BACH1 is required for timely progression through S phase.	BRIP1 BRCA2	1.31e-04	5	127	2	17664283
Pubmed	Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication.	BRIP1 BRCA2	1.31e-04	5	127	2	19748364
Pubmed	Doubling the size of the glucocorticoid receptor ligand binding pocket by deacylcortivazol.	NCOA3 PPARGC1A	1.31e-04	5	127	2	18160712
Pubmed	The human olfactory receptor gene family.	OR1M1 OR7G1 OR7A5 OR5G3 OR13C5 OR14C36 OR6V1 OR1Q1 OR1P1	1.74e-04	541	127	9	14983052
Pubmed	IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes.	IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-28	1.87e-04	77	127	4	15608191
Pubmed	A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.	EMILIN3 SYNPO BIRC6 SGK2 WDR11 ASXL3 PDCD11 RAI1	1.93e-04	431	127	8	33660365
Pubmed	A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro.	NCOA3 PPARGC1A	1.97e-04	6	127	2	16373399
Pubmed	PALB2 is an integral component of the BRCA complex required for homologous recombination repair.	BRIP1 BRCA2	1.97e-04	6	127	2	19369211
Pubmed	Repression of the Transactivating Capacity of the Oncoprotein PLAG1 by SUMOylation.	PIAS2 PLAGL2	1.97e-04	6	127	2	15208321
Pubmed	A massively parallel pipeline to clone DNA variants and examine molecular phenotypes of human disease mutations.	ARL2BP BRIP1 KLHL3 BUB1B	2.06e-04	79	127	4	25502805
Pubmed	HDAC2/3 binding and deacetylation of BubR1 initiates spindle assembly checkpoint silencing.	BRCA2 BUB1B	2.75e-04	7	127	2	28985013
Pubmed	Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.	BRIP1 BRCA2	2.75e-04	7	127	2	21356067
Pubmed	FBXL10 promotes ERRα protein stability and proliferation of breast cancer cells by enhancing the mono-ubiquitylation of ERRα.	NCOA3 PPARGC1A	2.75e-04	7	127	2	33450359
Pubmed	Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses.	BRIP1 BRCA2	2.75e-04	7	127	2	16485136
Pubmed	Mettl14-mediated m6A modification ensures the cell-cycle progression of late-born retinal progenitor cells.	BRIP1 BRCA2 ZNF292	2.86e-04	35	127	3	37269288
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TANC2 EXPH5 KLC2 WNK1 ANKRD27 ANLN TET1 BUB1B KMT2A BOD1L1 NR3C2	3.30e-04	861	127	11	36931259
Pubmed	The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus.	IGHV2-26 IGHV4-61 IGHV4-59 IGHV4-28	3.55e-04	91	127	4	9841928
Pubmed	Adamts17 is involved in skeletogenesis through modulation of BMP-Smad1/5/8 pathway.	FBN1 ADAMTS17	3.65e-04	8	127	2	31201465
Pubmed	EMILIN proteins are novel extracellular constituents of the dentin-pulp complex.	EMILIN3 FBN1	3.65e-04	8	127	2	32948785
Pubmed	Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif.	PIAS2 HIPK3	3.65e-04	8	127	2	10961991
Pubmed	The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.	WNK1 KLHL3	3.65e-04	8	127	2	23387299
Pubmed	Different noses for different people.	OR5G3 OR1P1	3.65e-04	8	127	2	12730696
Pubmed	KLHL2 interacts with and ubiquitinates WNK kinases.	WNK1 KLHL3	3.65e-04	8	127	2	23838290
Pubmed	5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complex.	TET1 WDR77	3.65e-04	8	127	2	25284789
Pubmed	Requirement of heterogeneous nuclear ribonucleoprotein C for BRCA gene expression and homologous recombination.	BRIP1 BRCA2	3.65e-04	8	127	2	23585894
Pubmed	Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor γ (PPARγ) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes.	NCOA3 PPARGC1A	3.65e-04	8	127	2	23178929
Pubmed	Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease.	SOBP USH2A	3.65e-04	8	127	2	16545802
Pubmed	The Penta-EF-Hand ALG-2 Protein Interacts with the Cytosolic Domain of the SOCE Regulator SARAF and Interferes with Ubiquitination.	FNDC3A MIA2	3.65e-04	8	127	2	32878247
Pubmed	Identification of potential regulatory motifs in odorant receptor genes by analysis of promoter sequences.	OR1P1 OR5H1	3.65e-04	8	127	2	16902085
Pubmed	Characterisation of the Cullin-3 mutation that causes a severe form of familial hypertension and hyperkalaemia.	WNK1 KLHL3	3.65e-04	8	127	2	26286618
Pubmed	A human MAP kinase interactome.	IFT140 ARL2BP ANK3 EXPH5 SYNPO WNK1 PIAS2 HIPK3	4.31e-04	486	127	8	20936779
Pubmed	Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance.	BRIP1 BRCA2	4.68e-04	9	127	2	28398198
Pubmed	Conserved overlapping gene arrangement, restricted expression, and biochemical activities of DNA polymerase ν (POLN).	BRIP1 BRCA2	4.68e-04	9	127	2	26269593
Cytoband	14q32.33	IGHV2-26 IGHV4-38-2 IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-30-4 IGHV4-28	3.66e-06	228	127	7	14q32.33
Cytoband	20q12	NCOA3 EMILIN3 KCNS1	4.01e-05	24	127	3	20q12
GeneFamily	Immunoglobulin heavy locus at 14q32.33	IGHV2-26 IGHV4-38-2 IGHV4-61 IGHV4-59 IGHV4-31 IGHV4-30-4 IGHV4-28	3.29e-05	187	87	7	349
GeneFamily	Zinc fingers MIZ-type	PIAS2 ZMIZ2	4.73e-04	7	87	2	85
GeneFamily	Olfactory receptors, family 1	OR1M1 OR1Q1 OR1P1	9.35e-04	40	87	3	147
GeneFamily	VPS9 domain containing	ANKRD27 RIN2	1.00e-03	10	87	2	928
GeneFamily	Ankyrin repeat domain containing	TANC2 ANK3 ANKRD27 ANKRD34B ANKRD12 AGAP7P	1.11e-03	242	87	6	403
GeneFamily	Zinc fingers CXXC-type	TET1 KMT2A	1.46e-03	12	87	2	136
GeneFamily	Endogenous ligands\|Minor histocompatibility antigens	WNK1 PDCD11 UTY	1.90e-03	51	87	3	870
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	BRIP1 BRCA2	4.11e-03	20	87	2	548
GeneFamily	PHD finger proteins\|Lysine demethylases	JMJD1C UTY	5.90e-03	24	87	2	485
Coexpression	LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE	TANC2 PDE4D ANK3 FNDC3A WNK1 PPARGC1A NR3C2	1.28e-05	171	118	7	M39234
Coexpression	LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET	TANC2 PDE4D ANK3 FNDC3A JMJD1C PPARGC1A NR3C2 ZNF292	1.35e-05	240	118	8	M39236
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3	TANC2 PDE4D SOBP EMILIN3 SYNPO FBN1 BRCA2 ZNF827 FMN1 ASXL3 ADAMTS17 BOD1L1 NR3C2 ANKRD12 QSER1	2.62e-05	834	110	15	Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	TANC2 ANK3 EMILIN3 WNK1 BIRC6 HIPK3 ASXL3 FOXP1 PLXNA2 AGTPBP1	3.20e-05	385	110	10	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#3	TANC2 PDE4D ANK3 SOBP EMILIN3 SYNPO FBN1 ZNF827 NR3C2 ANKRD12 UTY PLXNA2	3.81e-05	567	110	12	Facebase_RNAseq_e10.5_Olfactory Pit_2500_K3
CoexpressionAtlas	Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2	BRIP1 SLC43A3 IGF2BP3 OIT3 BRCA2 ANLN TET1 BUB1B ASPM QSER1	5.44e-05	410	110	10	GSM791122_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3	SPATA7 PDE4D SLC43A3 WNK1 BRCA2 TET1 BOD1L1 QSER1 HEATR5B ZNF292	8.39e-05	432	110	10	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	SPATA7 FNDC3A WNK1 PIAS2 PPARGC1A BRCA2 TET1 BOD1L1 QSER1 HEATR5B IQCK ZNF292	1.03e-04	629	110	12	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	ANK3 HUS1 EMILIN3 HIPK3 PPARGC1A ASPM FOXP1 AGTPBP1 ZNF292	1.30e-04	369	110	9	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	TANC2 PIAS2 ZXDB PPARGC1A IGF2BP3 SCML2 FOXP1 CPSF2 UTY ZNF292	2.41e-04	492	110	10	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	NCOA3 EMILIN3 FNDC3A SNX16 BIRC6 JMJD1C SCML2 ASXL3 TET1 ASPM ANKRD12 UTY PLXNA2	2.58e-04	801	110	13	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	ANK3 HUS1 EMILIN3 HIPK3 PPARGC1A PDLIM3 CLCA2 ASPM FOXP1 CPSF2 PLXNA2 AGTPBP1 ZNF292	2.74e-04	806	110	13	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000	BRIP1 SCML2 PDLIM3 BRCA2 ANLN PIK3CD FMN1 TET1 BUB1B ATF7IP2 PDCD11 ANKRD12 WDR77	2.88e-04	810	110	13	gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000	TANC2 NCOA3 PDE4D COL19A1 EMILIN3 BIRC6 HIPK3 LYVE1 SCML2 CLCA2 ASPM FOXP1 AGTPBP1	2.91e-04	811	110	13	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000
CoexpressionAtlas	B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1	BRIP1 SLC43A3 IGF2BP3 BRCA2 ANLN TET1 BUB1B ASPM QSER1	3.28e-04	418	110	9	GSM538350_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5	EMILIN3 SYNPO BRCA2 FMN1 ASXL3 ADAMTS17 BOD1L1 QSER1	3.31e-04	331	110	8	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5
CoexpressionAtlas	B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2	BRIP1 SLC43A3 IGF2BP3 BRCA2 ANLN TET1 BUB1B ASPM QSER1	3.34e-04	419	110	9	GSM538348_500
CoexpressionAtlas	B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2	BRIP1 SLC43A3 IGF2BP3 BRCA2 ANLN TET1 BUB1B ASPM QSER1	3.51e-04	422	110	9	GSM538355_500
CoexpressionAtlas	alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1	WNK1 BIRC6 PAPOLG ZNF827 TET1 KMT2A FOXP1 ZNF292	3.66e-04	336	110	8	GSM538413_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000	TANC2 PDE4D COL19A1 PIAS2 ZXDB PPARGC1A IGF2BP3 SCML2 CLCA2 FOXP1 CPSF2 UTY ZNF292	3.89e-04	836	110	13	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNPO ZXDB LYVE1 PDLIM3 ASPM GLIPR1L1 DDX28	4.42e-08	119	124	7	c3f1223356e7f245a460ea5568a223e34e458dc1
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 SLC43A3 BRCA2 ANLN BUB1B ASPM FBXO43	2.95e-07	157	124	7	1ccb07a38d3fb606ee5fbc0437655f49baaaa62c
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	ANK3 KCNS1 FOXP1 NR3C2 ANKRD12 GOLGA8A UTY	3.64e-07	162	124	7	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 SCML2 BRCA2 ANLN BUB1B ASPM FBXO43	4.47e-07	167	124	7	bc132b51dec4e8f1cd2b2cd89f83641976e09292
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 FBN1 BRCA2 ANLN BUB1B ASPM FBXO43	5.25e-07	171	124	7	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 FBN1 BRCA2 ANLN BUB1B ASPM FBXO43	5.25e-07	171	124	7	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 BRCA2 ANLN PIK3CD BUB1B ASPM FBXO43	5.25e-07	171	124	7	55c7bf7211587fa08df13c0a4ff5b78a85d5439e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SGK2 SPATC1 PPARGC1A FMN1 ASXL3 FAM222A ADAMTS17	6.87e-07	178	124	7	dfed0fbf7a73b8a9e00178ec58dc4592b271c344
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PPARGC1A FICD BRCA2 ANLN BUB1B ASPM FBXO43	7.14e-07	179	124	7	021d782134126c6f7dce6b6ea50cc54bdaa39987
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SGK2 SPATC1 PPARGC1A FMN1 ASXL3 FAM222A ADAMTS17	7.14e-07	179	124	7	d0fa700648db8ce76a8aa689879a25048299fa40
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE4D EXPH5 WNK1 KLHL3 PPARGC1A FMN1 NR3C2	7.14e-07	179	124	7	666072c0e8448dbaec1683d18368ec2502453f90
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SGK2 SPATC1 PPARGC1A FMN1 ASXL3 FAM222A ADAMTS17	7.14e-07	179	124	7	2e49b215b71438400aebb483f2c2c08d5e956961
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 WNK1 KLHL3 PPARGC1A FMN1 ADAMTS17 NR3C2	7.98e-07	182	124	7	5f513bbb7125956eb528e3120de3fd776770a7c3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 FBN1 BRCA2 ANLN BUB1B ASPM FBXO43	9.57e-07	187	124	7	e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 FBN1 BRCA2 ANLN BUB1B ASPM FBXO43	9.57e-07	187	124	7	cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 BRCA2 ANLN PIK3CD BUB1B ASPM FBXO43	9.57e-07	187	124	7	73931a5ea73799095daff100b5f18853c57c74dc
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 WNK1 KLHL3 PPARGC1A FMN1 ADAMTS17 NR3C2	9.91e-07	188	124	7	bc089cd73d283ed7d2ecbb3936673b4edc89f666
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 WNK1 KLHL3 PPARGC1A FMN1 ADAMTS17 NR3C2	9.91e-07	188	124	7	eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 WNK1 KLHL3 PPARGC1A FMN1 ADAMTS17 NR3C2	1.03e-06	189	124	7	977a813e5d7a5a561c1fced2bbf21c20056b88d8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 WNK1 KLHL3 PPARGC1A FMN1 ADAMTS17 NR3C2	1.03e-06	189	124	7	975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 WNK1 KLHL3 PPARGC1A FMN1 ADAMTS17 NR3C2	1.03e-06	189	124	7	7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 PDE4D KLHL3 PPARGC1A FMN1 ASXL3 NR3C2	1.06e-06	190	124	7	4836ea19308d2a96694f12ab0653b7ce7b101d2f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 WNK1 KLHL3 PPARGC1A FMN1 ADAMTS17 NR3C2	1.06e-06	190	124	7	e252e925600e6457fa6e362a55217f4cffa75cdb
ToppCell	RV-08._Macrophage\|World / Chamber and Cluster_Paper	LYVE1 BRCA2 ANLN PIK3CD FMN1 BUB1B ASPM	1.14e-06	192	124	7	a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	ASPM PDCD11 KMT2A BOD1L1 ANKRD12 GOLGA8A ZNF292	1.14e-06	192	124	7	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	ANK3 JMJD1C KMT2A FOXP1 ANKRD12 GOLGA8A UTY	1.14e-06	192	124	7	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	RV-08._Macrophage\|RV / Chamber and Cluster_Paper	LYVE1 BRCA2 ANLN PIK3CD FMN1 BUB1B ASPM	1.18e-06	193	124	7	12bf98a280f87e4d8f0c6887dfc855da72e47ac1
ToppCell	Healthy/Control-T/NK_proliferative\|Healthy/Control / Disease group and Cell class	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43 HYDIN	1.27e-06	195	124	7	957458fdc39723f4a31bd7fd3ce32891aa3fd462
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 EXPH5 WNK1 KLHL3 PPARGC1A FMN1 ADAMTS17	1.27e-06	195	124	7	a38d9dc6192aea673d96fda6b25e81223fda3abf
ToppCell	mLN-B_cell-B_cell_cycling\|mLN / Region, Cell class and subclass	ANLN BUB1B ASPM IGHV4-59 IGKV6-21 IGHV4-31 IGHV4-28	1.35e-06	197	124	7	806dddcca85c82bd642008d930c8db16b613d88e
ToppCell	mLN-(2)_B_cell-(24)_B_cell_cycling\|mLN / shred on region, Cell_type, and subtype	ANLN BUB1B ASPM IGHV4-59 IGKV6-21 IGHV4-31 IGHV4-28	1.35e-06	197	124	7	70fff2d6723f259e18e7a21d22dc46d71f0759ce
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BIRC6 JMJD1C KMT2A BOD1L1 ANKRD12 GOLGA8A ZNF292	1.50e-06	200	124	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BRIP1 ANKRD34B BRCA2 ANLN BUB1B ASPM FBXO43	1.50e-06	200	124	7	af3dc76b4507bf4edd265169f5dfbbb8a19eb394
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	WNK1 KLHL3 FMN1 FAM222A ADAMTS17 USH2A	2.69e-06	140	124	6	5e81fa3a19d23f0e9cae3878431ca1f78dff7238
ToppCell	Dividing_Macrophages-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	SRRM5 SPATC1 ANLN BUB1B ASPM FBXO43	3.71e-06	148	124	6	66b51aa6690bf8fbc90fa5a6f86191703e2d5046
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	ANK3 JMJD1C FOXP1 ANKRD12 GOLGA8A UTY	5.03e-06	156	124	6	1545169694f686d28648a68b552c2ae606599d66
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 WNK1 SGK2 KLHL3 FMN1 GOLGA8A	5.03e-06	156	124	6	4d2679e7639758c49fc25a2deb9109b08f0a3e57
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SCML2 BRCA2 ANLN BUB1B ASPM FBXO43	6.94e-06	165	124	6	eec2d327c94832d1390314c93ef6a2be4648478b
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	7.18e-06	166	124	6	2642544070564debe2deb2938d2c33997bf5ef02
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	7.43e-06	167	124	6	50c29ea660bf07b890e4ac1a1985d0761d863dee
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	7.69e-06	168	124	6	d35944fd9fea9934ce1e76b2b35d48e2300cca61
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	7.95e-06	169	124	6	b253a4a50c06d36228fcd5d856c57202cbac158f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	7.95e-06	169	124	6	0bc8ef341ce307b19018d4ac8de0a4d04254209d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 SLC43A3 ANLN BUB1B ASPM FBXO43	8.23e-06	170	124	6	21bfe070e63722672176052b386167ea4c3dc4e5
ToppCell	metastatic_Brain-B_lymphocytes-Plasma_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGKV6D-21 IGHV4-61 IGHV4-59 IGKV6-21 IGHV4-31 IGHV4-28	8.23e-06	170	124	6	53634da9e9c72f6400639954c286c6e38ea5a188
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 EXPH5 WNK1 KLHL3 PPARGC1A FMN1	9.09e-06	173	124	6	0c74bdb40e635d906fd180412c23bf7fed61621e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	WNK1 KLHL3 PPARGC1A FMN1 ADAMTS17 OR5H1	9.09e-06	173	124	6	4bc6d93716f093b460c8b047199db8cab5fea720
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	9.39e-06	174	124	6	84da9faff088d05233183b425385beb054c92d1b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 ANLN PIK3CD BUB1B ASPM FBXO43	9.39e-06	174	124	6	7b318796728001c17b4043d2b033330c7be40c78
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	9.39e-06	174	124	6	dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e
ToppCell	RSV-Healthy-2\|Healthy / Virus stimulation, Condition and Cluster	SOBP ANLN FMN1 TET1 ASPM WDR77	9.71e-06	175	124	6	c47440c0b0513e67fe13b85f10dd8a8d42d0e9a3
ToppCell	RSV-Healthy-2\|RSV / Virus stimulation, Condition and Cluster	SOBP ANLN FMN1 TET1 ASPM WDR77	9.71e-06	175	124	6	0e97189585b7afaf3bd622c3ef10c86412393829
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	9.71e-06	175	124	6	876cea684faf42ff3eb4623ad6d7a1fb1276ee02
ToppCell	CV-Severe-7\|CV / Virus stimulation, Condition and Cluster	NCOA3 SLC43A3 ANLN PDCD11 UTY SLC9A6	1.00e-05	176	124	6	3de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	NCOA3 SLC43A3 ANLN PDCD11 UTY SLC9A6	1.04e-05	177	124	6	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	1.04e-05	177	124	6	73ba0f0b4b33f10e9f036d6d9befa48a1258e682
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SYNPO ZXDB LYVE1 PDLIM3 GLIPR1L1 DDX28	1.14e-05	180	124	6	baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SGK2 SPATC1 PPARGC1A FMN1 FAM222A ADAMTS17	1.14e-05	180	124	6	9e09b3dfe344b5d50520711513d389865d73a861
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	1.14e-05	180	124	6	401df9cddcbca1eb8f0d2687bcacd98e95dc1493
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SYNPO ZXDB LYVE1 PDLIM3 GLIPR1L1 DDX28	1.14e-05	180	124	6	2d608b9394d28d19cfc85c6ac94003d5177c8a92
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SYNPO ZXDB LYVE1 PDLIM3 GLIPR1L1 DDX28	1.14e-05	180	124	6	0f9b27054358c4737eed06c8ea01987cccc3cb55
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL19A1 IGHV4-61 IGHV4-59 IGKV6-21 IGHV4-31 IGHV4-28	1.18e-05	181	124	6	700adfb41e4e377530f0dd31be89e12f109f3469
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	WNK1 KLHL3 PPARGC1A FMN1 ADAMTS17 OR5H1	1.18e-05	181	124	6	e0abf2707d9e0aa942c657eef7d2cbcd02f060dd
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	ANK3 JMJD1C FOXP1 ANKRD12 GOLGA8A UTY	1.18e-05	181	124	6	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 WNK1 PIAS2 KLHL3 PPARGC1A FMN1	1.25e-05	183	124	6	2f0ee40e69ad1259e56e8ee4b352736900eb8901
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5\|TCGA-Liver / Sample_Type by Project: Shred V9	IGF2BP3 BRCA2 ANLN BUB1B ASPM FBXO43	1.25e-05	183	124	6	f604a8b62c7088fad8365dbf8d910fc980bd3ba8
ToppCell	Mild-Lymphoid-B\|Mild / Condition, Lineage, Cell class and cell subclass	COL19A1 IGHV4-61 IGHV4-59 IGKV6-21 IGHV4-31 IGHV4-28	1.25e-05	183	124	6	9b64d2d143525e6f48a191facfd101462ff36324
ToppCell	Mild-Lymphoid-B-\|Mild / Condition, Lineage, Cell class and cell subclass	COL19A1 IGHV4-61 IGHV4-59 IGKV6-21 IGHV4-31 IGHV4-28	1.25e-05	183	124	6	b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EXPH5 WNK1 KLHL3 PPARGC1A FMN1 NR3C2	1.25e-05	183	124	6	2e831a4d99c6f983793df71c0994124c943c6da9
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	COL19A1 IGHV4-61 IGHV4-59 IGKV6-21 IGHV4-31 IGHV4-28	1.29e-05	184	124	6	3f8a359e40bebe58545f708682e5e5d1b70cf5cb
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	COL19A1 IGHV4-61 IGHV4-59 IGKV6-21 IGHV4-31 IGHV4-28	1.29e-05	184	124	6	64bede8db709fd32f40c03265b96f0b12155bb8a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL19A1 IGHV4-61 IGHV4-59 IGKV6-21 IGHV4-31 IGHV4-28	1.33e-05	185	124	6	609080adb2cfb105bb7b8efb617553833299f371
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	BRIP1 IGF2BP3 BRCA2 ANLN BUB1B ASPM	1.33e-05	185	124	6	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	1.33e-05	185	124	6	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE4D WNK1 KLHL3 PPARGC1A FMN1 NR3C2	1.37e-05	186	124	6	d65fa6d8e8a195ea10cfde1499d096d6acf7a634
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SGK2 SPATC1 PPARGC1A FMN1 FAM222A ADAMTS17	1.41e-05	187	124	6	85e58a312fc325e4063a2d250666b99b8f99beb6
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SGK2 SPATC1 PPARGC1A FMN1 FAM222A ADAMTS17	1.41e-05	187	124	6	52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	1.41e-05	187	124	6	9351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	1.41e-05	187	124	6	057569c9437219ecc396aa6e673b1178a2273837
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	WNK1 KLHL3 PPARGC1A FMN1 ADAMTS17 NR3C2	1.50e-05	189	124	6	f51cdc9a47371cab8ed9ae63a6f14da07ede446c
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	PDE4D ANK3 FNDC3A BOD1L1 UTY PLXNA2	1.50e-05	189	124	6	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	1.55e-05	190	124	6	31de1727822e9818652946dfb962daee77ffad68
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	WNK1 KLHL3 PPARGC1A FMN1 ADAMTS17 NR3C2	1.55e-05	190	124	6	b94df372bc08de11585b2467dba8c8fffff5cd92
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	BRIP1 BRCA2 ANLN BUB1B ASPM PLXNA2	1.55e-05	190	124	6	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	Endothelial-D_(cycle)\|World / shred on cell class and cell subclass (v4)	BRIP1 SLC43A3 LYVE1 ANLN BUB1B ASPM	1.59e-05	191	124	6	49a4d8f181558e3be9527a8ff9a178f3bb01323c
ToppCell	COVID-19-kidney-Proliferating_T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	1.59e-05	191	124	6	bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell	COVID-19-kidney-CNT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE4D ANK3 SGK2 PPARGC1A ANKRD34B NR3C2	1.64e-05	192	124	6	760c6b9628de9693034b00c5025c5c4df94bb2e8
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TANC2 PDE4D BIRC6 JMJD1C FMN1 FOXP1	1.69e-05	193	124	6	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Control-Lymphoid-Proliferating_CD4_T_cells\|Control / Condition, Lineage and Cell class	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	1.69e-05	193	124	6	33d409d6ed1c606337248587ad997ac5f67f081d
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	1.74e-05	194	124	6	f39a471293ecc5c5967b00e772b8f48ebc9affbe
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	1.74e-05	194	124	6	f9070035553bc68106a9e0bdf4b507715a138aba
ToppCell	Control-Lymphoid_T/NK-T/NK_proliferative\|Control / Disease group, lineage and cell class	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	1.74e-05	194	124	6	9bbb124001fba7450f4639f47f9b720a483e7242
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	1.74e-05	194	124	6	a75ecd0b0a928d4646602f7d16a645f6b3df3af5
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	1.74e-05	194	124	6	17744fd6645cf5a447a01a83f07e8d305c2bcd9c
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BRIP1 SLC43A3 LYVE1 ANLN BUB1B ASPM	1.74e-05	194	124	6	3a49c7c86036e09a8cd0114988380d04ad1a26fb
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	1.74e-05	194	124	6	e14f66f7584909621b776292fbd52808273fd2ee
ToppCell	COVID-19-kidney-Proliferating_T_cell\|kidney / Disease (COVID-19 only), tissue and cell type	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	1.79e-05	195	124	6	7e05e56f8d0a7a052830c7db12b10dace7d10760
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE4D EXPH5 WNK1 KLHL3 PPARGC1A ANKRD34B	1.79e-05	195	124	6	3f517c6fc372bdcaf45b3af373414f13cbebd4ba
ToppCell	COVID-19-lung-Proliferative_fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	1.85e-05	196	124	6	2ce8a787f2731faa913d20342d73041d59468f27
ToppCell	COVID-19-lung-Proliferative_fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BRIP1 BRCA2 ANLN BUB1B ASPM FBXO43	1.85e-05	196	124	6	ca91d5e325875e7444809b80fcbd491d8899ea36
Disease	pseudohypoaldosteronism (is_implicated_in)	WNK1 KLHL3 NR3C2	2.56e-06	8	107	3	DOID:4479 (is_implicated_in)
Disease	Pseudohypoaldosteronism, Type I	WNK1 KLHL3 NR3C2	5.46e-06	10	107	3	C0268436
Disease	Pseudohypoaldosteronism	WNK1 KLHL3 NR3C2	5.46e-06	10	107	3	C0033805
Disease	Hyperpotassemia and Hypertension, Familial	WNK1 KLHL3 NR3C2	5.46e-06	10	107	3	C2713447
Disease	Pseudohypoaldosteronism, Type I, Autosomal Recessive	WNK1 KLHL3 NR3C2	5.46e-06	10	107	3	C1449843
Disease	Pseudohypoaldosteronism, Type II	WNK1 KLHL3 NR3C2	5.46e-06	10	107	3	C1449844
Disease	Pseudohypoaldosteronism, Type I, Autosomal Dominant	WNK1 KLHL3 NR3C2	5.46e-06	10	107	3	C1449842
Disease	progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma	PDE4D EYS IGF2BP3 ADAMTS17	1.65e-05	42	107	4	EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354
Disease	Neurodevelopmental Disorders	TANC2 ASXL3 KMT2A FOXP1 ZNF292	2.30e-05	93	107	5	C1535926
Disease	Weill-Marchesani syndrome (implicated_via_orthology)	FBN1 ADAMTS17	3.90e-05	3	107	2	DOID:0050475 (implicated_via_orthology)
Disease	Retinitis Pigmentosa	SPATA7 IFT140 ARL2BP EYS USH2A	3.95e-05	104	107	5	C0035334
Disease	Pseudohypoaldosteronism type 2A	WNK1 KLHL3	7.78e-05	4	107	2	cv:C1840389
Disease	Pseudohypoaldosteronism, type 2	WNK1 KLHL3	7.78e-05	4	107	2	cv:C1449844
Disease	Weill-Marchesani syndrome	FBN1 ADAMTS17	7.78e-05	4	107	2	cv:C0265313
Disease	Weill-Marchesani syndrome (is_implicated_in)	FBN1 ADAMTS17	7.78e-05	4	107	2	DOID:0050475 (is_implicated_in)
Disease	retinitis pigmentosa (implicated_via_orthology)	EYS USH2A AGTPBP1	1.27e-04	27	107	3	DOID:10584 (implicated_via_orthology)
Disease	pseudohypoaldosteronism (implicated_via_orthology)	WNK1 KLHL3	1.94e-04	6	107	2	DOID:4479 (implicated_via_orthology)
Disease	Autism Spectrum Disorders	TET1 FOXP1 USH2A RAI1	2.64e-04	85	107	4	C1510586
Disease	cognitive function measurement, self reported educational attainment	TANC2 PDE4D BIRC6 JMJD1C ZMIZ2 FOXP1 AFG1L	3.20e-04	355	107	7	EFO_0004784, EFO_0008354
Disease	heart disease (implicated_via_orthology)	PPARGC1A FBN1 PIK3CD	3.57e-04	38	107	3	DOID:114 (implicated_via_orthology)
Disease	prostate carcinoma	TANC2 IFT140 EXPH5 WDR11 ZNF827 ANLN FMN1 TRIM8 FOXP1 QSER1 AGAP7P	3.97e-04	891	107	11	EFO_0001663
Disease	Liver carcinoma	LYVE1 IGF2BP3 OIT3 ANLN BUB1B ASPM KMT2A SLC25A47	5.30e-04	507	107	8	C2239176
Disease	coffee consumption measurement	BIRC6 PPARGC1A EYS HYDIN RAI1	5.40e-04	182	107	5	EFO_0006781
Disease	cerebral palsy (implicated_via_orthology)	ADD2 AGAP7P	5.75e-04	10	107	2	DOID:1969 (implicated_via_orthology)
Disease	cholesterol to total lipids in large VLDL percentage	TDRD15 JMJD1C MYRF	5.89e-04	45	107	3	EFO_0022236
Disease	serum IgG glycosylation measurement	CWF19L2 COL19A1 EYS IGF2BP3 FMN1 ADAMTS17 FOXP1 USH2A	6.49e-04	523	107	8	EFO_0005193
Disease	fibrinogen measurement	DCHS2 JMJD1C WDR11 NR3C2	6.79e-04	109	107	4	EFO_0004623
Disease	amino acid measurement	TANC2 BRIP1 PDE4D SYNPO FMN1 ATF7IP2 OR1P1 NR3C2 PLXNA2	8.22e-04	678	107	9	EFO_0005134
Disease	omega-3 polyunsaturated fatty acid measurement	TDRD15 JMJD1C ZMIZ2 MYRF	9.13e-04	118	107	4	EFO_0010119
Disease	triglycerides to total lipids in very large VLDL percentage	TDRD15 JMJD1C MYRF	9.52e-04	53	107	3	EFO_0022340
Disease	cholesteryl esters to total lipids in very large VLDL percentage	TDRD15 JMJD1C MYRF	9.52e-04	53	107	3	EFO_0022258
Disease	cholesterol to total lipids in very large VLDL percentage	TDRD15 JMJD1C MYRF	1.01e-03	54	107	3	EFO_0022244
Disease	parathyroid hormone measurement	PDE4D FMN1 RIN2	1.06e-03	55	107	3	EFO_0004752
Disease	leukemia	NCOA3 BRIP1 KMT2A	1.06e-03	55	107	3	C0023418
Disease	neuroticism measurement, cognitive function measurement	BIRC6 JMJD1C ASXL3 ZMIZ2 FOXP1 NR3C2 RAI1 AFG1L	1.08e-03	566	107	8	EFO_0007660, EFO_0008354
Disease	cholesteryl esters to total lipids in large VLDL percentage	TDRD15 JMJD1C MYRF	1.12e-03	56	107	3	EFO_0022250
Disease	Fanconi anemia	BRIP1 BRCA2	1.15e-03	14	107	2	cv:C0015625
Disease	Hereditary Breast and Ovarian Cancer Syndrome	BRIP1 BRCA2	1.15e-03	14	107	2	C0677776
Disease	free cholesterol to total lipids in medium VLDL percentage	TDRD15 JMJD1C MYRF	1.18e-03	57	107	3	EFO_0022284
Disease	docosahexaenoic acid measurement	TDRD15 JMJD1C ZMIZ2 MYRF	1.20e-03	127	107	4	EFO_0007761
Disease	free cholesterol to total lipids in very large VLDL percentage	TDRD15 JMJD1C MYRF	1.30e-03	59	107	3	EFO_0022289
Disease	fourth ventricle volume measurement	CWF19L2 ADD2	1.51e-03	16	107	2	EFO_0010303
Disease	triglycerides to total lipids in medium VLDL percentage	TDRD15 JMJD1C MYRF	1.57e-03	63	107	3	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	TDRD15 JMJD1C MYRF	1.57e-03	63	107	3	EFO_0022239
Disease	cholesteryl esters to total lipids in medium VLDL percentage	TDRD15 JMJD1C MYRF	1.64e-03	64	107	3	EFO_0022253
Disease	respiratory symptom change measurement, response to placebo	PPARGC1A ATF7IP2	1.71e-03	17	107	2	EFO_0008344, EFO_0010068
Disease	Microcephaly	BUB1B SLC9A6 ZNF292	1.88e-03	67	107	3	C0025958
Disease	Bone marrow hypocellularity	BRIP1 BRCA2	1.92e-03	18	107	2	C1855710
Disease	Nonorganic psychosis	ANK3 SOBP TET1	2.04e-03	69	107	3	C0349204
Disease	migraine disorder, endometriosis	SNX16 EYS FOXP1	2.40e-03	73	107	3	EFO_0001065, MONDO_0005277
Disease	pentachlorophenol measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022071
Disease	parathion measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022070
Disease	potassium chromate measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022072
Disease	mercuric chloride measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022068
Disease	heptachlor epoxide measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022067
Disease	methoxychlor measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022069
Disease	4,6-dinitro-o-cresol measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022053
Disease	2,4,5-trichlorophenol measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022052
Disease	azinphos methyl measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022055
Disease	aldrin measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022054
Disease	dicofol measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022060
Disease	disulfoton measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022062
Disease	dieldrin measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022061
Disease	endrin measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022064
Disease	endosulfan measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022063
Disease	heptachlor measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022066
Disease	ethion measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022065
Disease	chlorpyrifos measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022057
Disease	cadmium chloride measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022056
Disease	diazinon measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022059
Disease	dibutyl phthalate measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0022058
Disease	environmental exposure measurement	PDE4D EYS USH2A	2.40e-03	73	107	3	EFO_0008360
Disease	Retinitis pigmentosa	SPATA7 EYS USH2A	2.49e-03	74	107	3	cv:C0035334
Disease	DDT metabolite measurement	PDE4D EYS USH2A	2.49e-03	74	107	3	EFO_0007886
Disease	Precursor B-cell lymphoblastic leukemia	KMT2A FOXP1	2.62e-03	21	107	2	C1292769
Disease	social deprivation, COVID-19	RIN2 ADAMTS17	2.62e-03	21	107	2	EFO_0009696, MONDO_0100096
Disease	BREAST CANCER	BRIP1 BRCA2	2.62e-03	21	107	2	114480
Disease	docosahexaenoic acid to total fatty acids percentage	JMJD1C MYRF	2.62e-03	21	107	2	EFO_0022262
Disease	nucleus accumbens volume	BIRC6 USH2A	2.87e-03	22	107	2	EFO_0006931
Disease	Leber Congenital Amaurosis	SPATA7 IFT140	2.87e-03	22	107	2	C0339527
Disease	dyslexia	TANC2 PDE4D HEATR5B AFG1L	2.91e-03	162	107	4	EFO_0005424
Disease	diastolic blood pressure, systolic blood pressure	BRIP1 PDE4D ANK3 EMILIN3 PPARGC1A FBN1 CLCA2 NR3C2	3.08e-03	670	107	8	EFO_0006335, EFO_0006336
Disease	sphingomyelin measurement	TDRD15 OR7G1 JMJD1C USH2A MYRF	3.49e-03	278	107	5	EFO_0010118

Protein segments in the cluster

Peptide	Gene	Start	Entry
SVASTSSIKCLQIPE	BUB1B	691	O60566
LPSKSVCNTSVLSSS	FAM222A	391	Q5U5X8
SGLPSLVTKLSASCT	ACOX2	421	Q99424
LTSKVCLDVTSVEPS	ANTXRL	246	A6NF34
SLATCPSSVSVEVSA	BIRC6	3231	Q9NR09
KTSSCSSLQREPVST	C2orf78	816	A6NCI8
SDVPTKCISTTESIE	CPSF2	516	Q9P2I0
TITTFLCPEKESTSA	ADGRG4	1371	Q8IZF6
KVRIICSASTPISSL	AFG1L	401	Q8WV93
LSSLAVSCPLTSLVS	ATP5MC2	41	Q06055
SGLVVTSLCKSSSLP	ARL2BP	141	Q9Y2Y0
NKKISTSCSVIPETS	ANKRD12	436	Q6UB98
ESSCKVTSPTTYVLD	AGTPBP1	1161	Q9UPW5
PILSATVTKRKATCT	ASPM	491	Q8IZT6
SSLTGETTPCSKVTA	ATP2C1	186	P98194
IPKCIESTPISATTE	ASXL3	1296	Q9C0F0
KSKVSTCLLVTDPRS	ADAMTS17	441	Q8TE56
SKAKPESVSTCSVTS	RAI1	546	Q7Z5J4
STTKIKSCSTEQPLT	QSER1	276	Q2KHR3
TFLKPCESESKTTRS	FMN1	811	Q68DA7
IVRLKPSCSTDSSFT	IQCK	11	Q8N0W5
TIPLSKISCTDSSIN	OR5H15	181	A6NDH6
LSFADICVTSTTIPK	OR7A5	66	Q15622
ATCTTPSEIDIKTAS	ANKRD34B	181	A5PLL1
LVPCKGSLSSSIQST	ANKRD27	36	Q96NW4
SVSTGSSRPSKICLV	NR3C2	591	P08235
ESKSPSKTTVRCLEA	LYVE1	306	Q9Y5Y7
LDKTCLSIVPSQTIS	EYS	1661	Q5T1H1
VKPSQTLSLTCTVSG	IGHV4-31	31	P0DP07
SVTPKEKVTITCRAS	IGKV6-21	31	A0A0C4DH24
PVKSTTSITDAKSCE	ANLN	296	Q9NQW6
TLSASLPLDSTVICS	JMJD1C	1511	Q15652
TLITACSSESLVSKG	KIAA1109	3371	Q2LD37
AATKCTSPSTELSIT	FICD	71	Q9BVA6
VKPTETLTLTCTVSG	IGHV2-26	31	A0A0B4J1V2
VKPSQTLSLTCTVSG	IGHV4-30-4	31	P0DP06
VKPSETLSLTCTVSG	IGHV4-61	31	A0A0C4DH41
NTTTLTCLAPSLTTD	PLXNA2	1091	O75051
SVTPKEKVTITCRAS	IGKV6D-21	31	A0A0A0MT36
VPTSCVNSLLDSTTI	OR14C36	76	Q8NHC7
SKTFSTCIPHLVVVT	OR14L1P	236	Q8NHC6
SLVESCFATPTSKID	OIT3	431	Q8WWZ8
KTLCTQDSESTEIPL	PDE4D	766	Q08499
PEDCSVSSITKVSVV	CWF19L2	211	Q2TBE0
VLTSKPSTVRLISCS	GANC	101	Q8TET4
TTCVSSSAPSKTSLI	FOXP1	256	Q9H334
SPDAVTTITSSKLHC	DDX28	346	Q9NUL7
SCIEKLSKTESISVP	EXPH5	981	Q8NEV8
SLPSKLFSCVSISVV	KCNS1	216	Q96KK3
VKPSDTLSLTCAVSG	IGHV4-28	31	A0A0C4DH34
KPSSTCSARLTVVIT	OR13C5	236	Q8NGS8
SSADTETKPAVCSVV	HIPK3	981	Q9H422
VKPSETLSLTCTVSG	IGHV4-59	31	P01825
ILSTPEGTSAACKSI	IGF2BP3	246	O00425
VKPSETLSLTCTVSG	IGHV4-38-2	31	P0DP08
CKVDSPTVNTTLRSL	KLC2	441	Q9H0B6
TIPLSKISCTDSSIN	OR5H1	181	A6NKK0
FPSLSSTTTILCTVE	DCHS2	1806	Q6V1P9
SCPQSETIISSLKID	BRIP1	1066	Q9BX63
ETLEASKQVSPCSTR	PPARGC1A	436	Q9UBK2
TTVLRIPSASSCQKA	OR6V1	221	Q8N148
LSFTDICLTTTTVPK	OR7G1	66	Q8NGA0
LVTSTLKTEEVTSCS	FBXO43	206	Q4G163
VDSTVKTVSPPTVCT	PAPOLG	591	Q9BWT3
ISSATTIKCAESLQP	BOD1L1	2156	Q8NFC6
SSVTTTESIKRSCPS	FAM189B	56	P81408
SGSKTPITTKLTVSC	HYDIN	5086	Q4G0P3
AATVTILSDLPSLCS	HEATR5B	1756	Q9P2D3
IACRSAPVSKTLSSS	C2CD2	461	Q9Y426
KVSKISPCDVSLETS	BRCA2	1941	P51587
STSVTVRDKTEESCP	COL19A1	21	Q14993
ECSSESTLDPTKTIC	FBN1	831	P35555
SEVECTVSSLLPGKT	FNDC3A	716	Q9Y2H6
TLACTPISSSKSDGL	AGAP7P	326	Q5VUJ5
SICFSPSISSTTIPK	AGAP7P	351	Q5VUJ5
LTTSSCVDVKSRIPV	ANK3	3901	Q12955
CMAALTVTLTVLSSP	HLA-DRB4	11	P13762
SVITRTTEITKCSPS	ATF7IP2	56	Q5U623
EKTLCLSTPSSSTVK	KMT2A	986	Q03164
VCSLISSDKLTVSSE	KLHL3	196	Q9UH77
CLVATTSSKIPSITD	GLIPR1L1	16	Q6UWM5
CTPSTTSAILDSLVA	EMILIN3	521	Q9NT22
RCSSSGSTISILPSK	IFT140	576	Q96RY7
PELSVSSVSTLKKIC	IPO13	541	O94829
TVSLVDTKSTSCVLS	WDR77	236	Q9BQA1
LSFVDICSSSSVVPK	OR5G3	66	P0C626
VSSQPCTKIESSSVL	PIAS2	436	O75928
SSSVLSKPCSVTVAS	PIAS2	446	O75928
SSDKEATVPCTEILT	MIA2	346	Q96PC5
CPSSVLTTVKEKASA	OR1M1	261	Q8NGA1
SCADIFSTSTTVPKA	OR1P1	81	Q8NH06
LALTDICFTSTTVPK	OR1Q1	66	Q15612
TSPCAVSSATLKDLE	GOLGA8A	21	A7E2F4
CSTSKPTSITTLEAA	USH2A	4341	O75445
SMSVSICPSSTEVLK	UTY	831	O14607
LSCEVQSSPTTLLVT	SLC9A6	131	Q92581
VSKSIGCTPDTVASS	SGK2	331	Q9HBY8
LTKAATDITTLCPSS	TCP11X1	246	B4DZS4
LTKAATDITTLCPSS	TCP11X2	151	Q5H9J9
ESKTPVSSCTIKSFT	TDRD15	1711	B5MCY1
CSTLLIDKVSTPATT	SYNPO	396	Q8N3V7
PCLTVSVELLSMSSS	HUS1	111	O60921
PLDSSCKESSVSVTS	NCOA3	641	Q9Y6Q9
CKESSVSVTSPSGVS	NCOA3	646	Q9Y6Q9
LSLPVCTVSLVSSVS	SLC25A47	56	Q6Q0C1
TSAITQRISPCSTLT	TANC2	121	Q9HCD6
STLAVALCSTVPSLA	SLC43A3	356	Q8NBI5
SSVSTVSTICPGDLK	PDLIM3	151	Q53GG5
STSRVFTTLVLCDKP	SKIV2L	866	Q15477
SCSSTVSVKEELSPV	PLAGL2	261	Q9UPG8
VSITKDSELPTCSCL	TET1	1411	Q8NFU7
SPKGVSCSEVTASSL	ADD2	171	P35612
PTTVSAKTDISICSG	CLCA2	381	Q9UQC9
TVVGPDSSKTLLCLS	PDCD11	1206	Q14690
SIKTRTPSELECSQT	RIN2	251	Q8WYP3
TLTQDSLPITVCSLS	RNASE13	101	Q5GAN3
STLCENSVSELLTPT	ZXDB	741	P98169
RSSELAVTPSTAKCQ	SRRM5	206	B3KS81
PVICSTSAASLKSLT	SCML2	321	Q9UQR0
ACVVPTATTKVPLST	SPATC1	246	Q76KD6
TVSPSDTANCSVTKI	SOBP	331	A7XYQ1
PEDCTVTQSKSSLTI	SPATA31D1	306	Q6ZQQ2
SKTSSIEECSSLPVF	ZNF292	1556	O60281
KTVSSSEVSVCSEPV	PIK3CD	356	O00329
SAKAAVDCSVPVSVS	SPATA7	61	Q9P0W8
DIPSSLLTSEKSTAC	ZMIZ2	786	Q8NF64
TTTCSLSPDSAILKL	ZNF827	201	Q17R98
LTVDTDTLTPSSTLC	ZXDA	726	P98168
VGVSEVTASKPCLSS	ZNF548	66	Q8NEK5
CIQLSSSTSTPTLAE	WNK1	1506	Q9H4A3
AVAPSKLLTSTTSTC	WNK1	1696	Q9H4A3
SLKACLVTTVTSSGP	WDR11	1031	Q9BZH6
SVCSSPLIRTKFTGT	SNX16	66	P57768
RTQTCTSSSLSPTKI	TRIM8	311	Q9BZR9
SSSPVSVVLCSLRSK	MYRF	1066	Q9Y2G1